PATENT CLAIM ANALYSIS

Application Number: 16186113
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-04
Patent Classification: ["514", "683000"]

Abstract:
A method is presented for treating herpes simplex virus (HSV) infection comprising: (a) locally administering a substance that induces a delayed type hypersensitivity (DTH) response to a patient at a site of an HSV lesion to induce a DTH response at the site of the lesion during one or more outbreaks of the HSV infection.

Claim (Index 32):
The pharmaceutical composition of  claim 31  consisting essentially of SADBE dissolved in DMSO.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 98.0
- Lexical Diversity: 1.53659
- Patent Class: 514.0
- Transitional Phrase Type: half
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14690459', '15681393', '14094061', '12572584', '12113833']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7816515660262894
- 35 USC 102 Novelty (BERT): 0.5343131872454187
- Combined Prediction Score: 0.7569177281482024
- Mean Citation Score: 241.533976
- Max Citation Score: 322.38947
- Similarity Product: 150.05221673685494

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test